Double-blind controlled assessment of the effect of intra-articular hydrocortisone and urokinase in rheumatoid arthritis.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007270:Injections, Intra-Articular; D007719:Knee Joint / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013256:Steroids / Q000627:therapeutic use; D013667:Technetium; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D005343:Fibrinolytic Agents; D013256:Steroids; D013667:Technetium; D014568:Urokinase-Type Plasminogen Activator; D006854:Hydrocortisone